Corporate Responsibility Standards Coming; Don't Be First Case, FDA Warns
Executive Summary
FDA staff continue to review their new standards for prosecuting corporate officers deemed responsible for violations they reasonably could have prevented. But an FDA litigator said there should not be many surprises once the standards are released
You may also be interested in...
Park Doctrine Could Be Limited By Upcoming Cases, Attorney Argues
As penalties increase under responsible corporate officer doctrine, attorney Allison Burroughs, a partner at Nutter McClennen & Fish, says to expect increased scrutiny.
FDA Prosecution Criteria For “Responsible” Execs Includes Seriousness, Obviousness Of Violations
Almost a year after signaling its intent to target more individual executives with misdemeanor prosecutions when their companies have broken the law, FDA has published its criteria for pursuing such cases.
FDA Prosecution Criteria For “Responsible” Execs Includes Seriousness, Obviousness Of Violations
Almost a year after signaling its intent to target more individual executives with misdemeanor prosecutions when their companies have broken the law, FDA has published its criteria for pursuing such cases.